AusBiotech’s Investment Advisory Group

 

AusBiotech is pleased to announce the formation of a new advisory group of experts at the forefront of life science investment and partnering in Australia to provide guidance and advice on our current and future investment programmes and events. The group is chaired by Lorraine Chiroiu, CEO, AusBiotech.

Glenn Cross   Director, Red Bluff Capital

Glenn Cross

Director, Red Bluff Capital

 
Dr Chris Nave   Managing Director, Brandon Capital Partners

Dr Chris Nave

Managing Director, Brandon Capital Partners

Dr Amanda Gillon   Chief Operating Officer Investments, Bioscience Managers

Dr Amanda Gillon

Chief Operating Officer Investments, Bioscience Managers

 
Scott Power   Senior Research Analyst, Morgans

Scott Power

Senior Research Analyst, Morgans

Sarah Meibush   Principal, OneVentures

Sarah Meibush

Principal, OneVentures